Adverse event totals18

The totals the trial posted for each group.

1 to 18 of 18

Total	Group	Affected	At risk
Total, all-cause mortality	KRAS Mutant
Total, all-cause mortality	EGFR Mutant
Total, all-cause mortality	KRAS and EGFR Wild Type
Total, all-cause mortality	EML4-ALK Translocation
Total, all-cause mortality	Modified EGFR Mutant
Total, all-cause mortality
Total, other adverse events	KRAS Mutant	28	28
Total, other adverse events	EGFR Mutant	35	35
Total, other adverse events	KRAS and EGFR Wild Type	33	34
Total, other adverse events	EML4-ALK Translocation	22	22
Total, other adverse events	Modified EGFR Mutant	31	31
Total, other adverse events		3	3
Total, serious adverse events	KRAS Mutant	17	28
Total, serious adverse events	EGFR Mutant	18	35
Total, serious adverse events	KRAS and EGFR Wild Type	22	34
Total, serious adverse events	EML4-ALK Translocation	6	22
Total, serious adverse events	Modified EGFR Mutant	11	31
Total, serious adverse events		2	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01124864/event-totals